Introducing Proteintech as a Manufacturer of Antibodies, Cytokines and Nanobodies.
Friday, March 22. 10:00. Læknagardur, room 343
DNA binding redistributes activation domain ensemble and accessibility in pioneer factor Sox2
Identifying causal protein candidates for common disease in the AGES-RS cohort using Mendelian randomization
Clinical Metabolomics of Acute Critical Illness and Links to The Endothelium
Oestrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients
Neuronal heterogeneity and plasticity in the olfactory bulb
Málþing til heiðurs Vilmundi Guðnasyni, forstöðulæknis Hjartaverndar og prófessor við Læknadeild Háskóla Íslands í tilefni sjötugsafmælis hans.
Scientific innovation, the potential and the pitfalls
Green actions in the lab: there really is no time to waste
Molecular pathology of cancer and the application of clinical sequencing on tumor samples at Landspitali
The potential role of Atlastin 2 in breast cancer progression
High-throughput synthetic biology approach to study human disease proteins in yeast.